×
FXG is a rules-based, modified equal-weighted consumer staples fund with a multi-factor "AlphaDEX" tilt, while PBJ is a tiered equal-weighted food-and-beverage fund with a heavier large-cap, blue-chip brand profile. PBJ holds roughly 30–32 names concentrated in branded staples; FXG holds about 41 names and adds a notable healthcare and mid-cap tilt through names like Cardinal Health and McKesson.
Different engines, same sector. FXG uses a factor-driven, modified equal-weight AlphaDEX strategy, while VDC is a broad, market-cap-weighted index fund. Cost gap is material. VDC charges a 0.09% expense ratio versus 0.63% for FXG, a structural cost advantage that compounds over time.
FXG is a rules-based, factor-driven ("smart beta") fund that selects consumer staples names from the Russell 1000 using the AlphaDEX methodology, while XLP is a passive, market-capitalization-weighted fund tracking the S&P 500's consumer staples segment. XLP holds roughly 38 large-cap names concentrated in mega-cap leaders, whereas FXG holds about 41 stocks with a meaningful tilt toward mid-cap food, agriculture, and distribution businesses.
FXG is a factor-tilted consumer staples fund using the AlphaDEX methodology, holding roughly 41 names with a meaningful mid-cap tilt and a 0.63% expense ratio. RSPS is an equal-weight, large-cap consumer staples fund tracking roughly 38 S&P 500 constituents at a lower 0.40% expense ratio.
FXG is a U.S.-focused, "smart beta" consumer staples fund that uses a modified equal-dollar weighting methodology, while KXI is a global, market-cap-weighted staples fund dominated by mega-cap brand leaders. KXI is materially cheaper at a 0.38% net expense ratio versus FXG's 0.63%, and it offers far broader diversification (roughly 95+ holdings versus about 41).
Different indexing philosophies: FXG is a rules-based, multi-factor "smart beta" fund, while IYK is a traditional market-cap-weighted index fund. Contrasting exposure: FXG tilts toward mid-cap food producers and distributors; IYK is dominated by large-cap branded consumer staples leaders.
FSTA is a low-cost, market-cap-weighted index fund tracking the MSCI USA IMI Consumer Staples 25/50 Index, while FXG is a rules-based, multi-factor fund built on a modified equal-dollar weighting of roughly 41 stocks selected from the Russell 1000. FSTA charges just 0.08% annually versus 0.63% for FXG, a wide cost gap that directly favors FSTA over long holding periods.
FXG tracks the StrataQuant Consumer Staples AlphaDEX Index using a multi-factor, tiered equal-weighting methodology, while PSCC tracks the S&P SmallCap 600 Capped Consumer Staples Index with a small-cap, market-cap-weighted approach. FXG holds roughly 41 large- and mid-cap names versus PSCC's roughly 27 small-cap names, giving FXG a more diversified and less concentrated portfolio.
Different scopes: FTXG is a concentrated food-and-beverage fund, while FXG offers broader consumer staples exposure with meaningful healthcare and food-distribution weightings. Portfolio depth: FTXG holds roughly 31 names, whereas FXG holds about 41, giving FXG a more diversified, less single-stock-dependent profile.
FSTA is a market-cap-weighted fund holding roughly 100 consumer staples names, while RSPS equally weights a much smaller set of about 37–39 S&P 500 staples constituents. FSTA carries a 0.08% expense ratio, dramatically lower than RSPS 's 0.40%, giving the Fidelity fund a meaningful long-term cost advantage.
Defensive tilt in an uncertain macro cycle: Consumer staples tend to hold up better when growth slows, which supports the ETF forecast if recession risks rise in 2026. Equal-weight structure reduces mega-cap concentration: RSPS gives mid-sized names like MNST and KR a weight comparable to giants, shifting the future outlook toward a broader swath of the sector.
Same sector, different construction: Both funds target U.S. consumer staples, but RSPS is equal-weighted while XLP is market-cap-weighted, producing meaningfully different exposure profiles. Concentration gap: XLP's top 10 holdings account for roughly 60% of assets, led by WMT and COST , while RSPS keeps each position near a 3% weight.
KXI offers broad, globally diversified consumer staples exposure across roughly 100 large-cap names, while PBJ is a concentrated, U.S.-centric food and beverage basket of about 30–33 stocks. KXI is meaningfully cheaper, with a 0.39% expense ratio versus PBJ’s 0.61%–0.63%, and it is far more liquid with a substantially larger asset base.
FXG is a U.S.-focused, rules-based (smart-beta) consumer staples fund with roughly 41 holdings and a higher 0.63% expense ratio; KXI is a globally diversified, market-cap-weighted fund of about 100 large-cap names with a lower 0.38% expense ratio. The two funds do not compete directly: FXG tilts toward mid-cap and U.S. names using the AlphaDEX selection methodology, while KXI anchors on mega-cap global staples leaders such as Walmart and Costco.
KXI offers global, market-cap-weighted consumer staples exposure across roughly 100 holdings, while RSPS equally weights about 38 U.S.-only large-cap staples names. Both funds charge nearly identical fees — about 0.39%–0.40% — so cost is not a meaningful differentiator in this ETF comparison.
GXPS offers pure U.S. large-cap consumer staples exposure, while KXI spans roughly 92 holdings across developed and emerging markets worldwide. Both funds are passively managed, market-cap-weighted vehicles, but GXPS tracks the MSCI USA Consumer Staples Index and KXI tracks the S&P Global 1200 Consumer Staples Sector Capped Index.
FSTA is a U.S.-only, market-cap-weighted fund tracking the MSCI USA IMI Consumer Staples 25/50 Index, while KXI tracks the S&P Global 1200 Consumer Staples Capped Index for diversified global exposure. Cost is a decisive structural difference: FSTA charges a 0.08% expense ratio versus roughly 0.38% for KXI.
KXI is a global, market-cap-weighted fund tracking the S&P Global 1200 Consumer Staples Sector Capped Index, while VDC tracks the U.S.-only MSCI US Investable Market Consumer Staples 25/50 Index. Cost structure differs sharply: VDC charges a 0.09% expense ratio versus 0.38% for KXI, a meaningful long-term cost advantage.
Exposure scope differs sharply: KXI delivers global consumer staples exposure across roughly 100 holdings, while XLP is a concentrated, U.S.-only portfolio of about 38 large-cap names. Cost is a decisive gap: XLP carries a 0.08% expense ratio versus 0.38% for KXI, giving XLP a clear cost-efficiency edge over time.
Rate sensitivity is the central macro driver. Consumer staples trade like long-duration assets because of their stable cash flows, so the path of Federal Reserve rate cuts and real yields will be a key swing factor for the ETF forecast. Global diversification offers a structural hedge. With roughly 40% of assets outside the United States, KXI's international sleeve can benefit if the U.S. dollar weakens as the Fed eases policy.